Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks.

Mohan P., Choi B., Yoon D., Kim G.

Animal Study on Cardiovascular Disease, published in Bioact Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bioact Mater (2025)
Country
China
Reported sample size
—
Source database
PubMed
PMID
41532008
PMCID
PMC12794435
DOI
10.1016/j.bioactmat.2025.12.017

Abstract (original English)

Engineering aligned musculoskeletal and cardiac tissues remains a key challenge due to the lack of mechanical cues in conventional bioinks. Here, we present a synergistic strategy combining fiber-reinforced collagen bioinks with a brush-assisted bioprinting (BAB) process to fabricate highly organized, functional tissue constructs. The bioink incorporates straight and coiled poly(ε-caprolactone) (PCL) microfibers to deliver spatially defined biophysical guidance, while the BAB process applies directional and homogeneous shear stress to align both fibers and cells during printing. This integrated approach enhances cytoskeletal organization and activates mechanosensitive pathways, including YAP/TAZ and PIEZO1 , promoting myogenic differentiation. In vitro , printed bioconstructs using C2C12 and H9C2 exhibited improved cell alignment, gene expression, and structural maturation. In a murine volumetric muscle loss (VML) model, BAB-fabricated human adipose-stem cell (hASC)-laden constructs restored muscle mass and function more effectively than control, with the coiled fiber group showing the significantly meaningful levels of muscle regeneration, reduced fibrosis, and human cell integration. Based on these results, this work can demonstrate a new platform for fabricating anisotropic tissue constructs and offer significant potential for translational applications in regenerative medic

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research